Biomarker-based Trial of NPC-1 for Alzheimer's Pathology

NCT07236190 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease
Mild Cognitive Impairment (MCI)
Subjective Cognitive Decline (SCD)

Interventions

COMBINATION_PRODUCT: natural product combination-1 (NPC1)

Sponsor

Massachusetts General Hospital